Full Length Research Paper
References
|
Adjé-Touré C, Bilé CE, Borget MY, Hertog K, Maurice C, Nolan ML, Nkengasong JN (2003). Polymorphism in Protease and Reverse Transcriptase and Phenotypic Drug Resistance of HIV-1 Recombinant CRF02_AG Isolates from Patients with No Prior Use of Antiretroviral Drugs in Abidjan, Côte d'Ivoire. Journal of Acquired Immune Deficiency Syndromes 34(1):111-113. |
|
|
Appah A, Beelen CJ, Kirkby D, Dong W, Shahid A, Foley B, Mensah M, Ganu V, Puplampu P, Amoah LE, Nii-Trebi NI (2023). Molecular Epidemiology of HIV-1 in Ghana: Subtype Distribution, Drug Resistance and Coreceptor Usage. Viruses 15(1):128. |
|
|
Bbosa N, Kaleebu P, Ssemwanga D (2019). HIV subtype diversity worldwide. Current Opinion in HIV and AIDS 14(3):153-160. |
|
|
Bivigou-Mboumba B, Iroungou BA, Moussavou-Boundzanga P, Mangouka LG, Akombi FL, Bouassa-Bouassa A, Francois-Souquière S, Nzenze JR (2022). HIV Genetic Diversity, Virological Failure, and Drug Resistance in Libreville, Capital of Gabon, before a Total Dolutegravir-Based Regimen Transition. World Journal of AIDS 12(3):156-168. |
|
|
Dechi JJR (2019). HIV resistance to antiretrovirals in a cohort of patients followed according to national recommendations in Abidjan (Republic of Côte d'Ivoire). |
|
|
Fang G, Weiser B, Kuiken C, Philpott SM, Rowland-Jones S, Plummer F, Kimani J, Shi B, Kaul R, Bwayo J, Anzala O (2004). Recombination following superinfection by HIV-1. Aids 18(2):153-159. |
|
|
Fultz PN (2004). HIV-1 superinfections: omens for vaccine efficacy? Aids 18(1):115-119. |
|
|
Hemelaar J, Elangovan R, Yun J, Dickson-Tetteh L, Kirtley S, Gouws-Williams E, Ghys PD, Alash'le G A, Agwale S, Archibald C, Avidor B (2020). Global and regional epidemiology of HIV-1 recombinants in 1990-2015: A systematic review and global survey. Lancet HIV 7(11):e772-81. |
|
|
Hu WS, Temin HM (1990). Retroviral recombination and reverse transcription. Science 250(4985):1227-1233. |
|
|
Louwagie J, McCutchan FE, Peeters M, Brennan TP, Sanders-Buell E, Eddy GA, Van Der Groen G, Fransen K, Gershy-Damet GM, Deleys R, Burke DS (1993). Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS 7(6):769-780. |
|
|
Oluniyi PE, Ajogbasile FV, Zhou S, Fred-Akintunwa I, Polyak CS, Ake JA, Tovanabutra S, Iroezindu M, Rolland M, Happi CT (2022). HIV-1 drug resistance and genetic diversity in a cohort of people with HIV-1 in Nigeria. AIDS 36(1):137-146. |
|
|
Sivay MV, Totmenin AV, Zyryanova DP, Osipova IP, Nalimova TM, Gashnikova MP, Ivlev VV, Meshkov IO, Chokmorova UZ, Narmatova E, Motorov U (2021). Characterization of HIV-1 Epidemic in Kyrgyzstan. Frontiers in Microbiology 12:753675. |
|
|
Toni TD, Recordon-Pinson P, Minga A, Ekouevi D, Bonard D, Bequet L, Huet C, Chenal H, Rouet F, Dabis F, Lafon ME, Salamon R, Masquelier B, Fleury HJ (2003). Presence of key drug resistance mutations in isolates from untreated patients of Abidjan, Côte d'Ivoire: ANRS 1257 study. AIDS Research and Human Retroviruses 19(8):713-717. |
|
|
Wagner T, Zuckerman NS, Wax M, Shirazi R, Gozlan Y, Girshengorn S, Marom R, Mendelson E, Turner D, Mor O (2022). HIV-1 Circulating Recombinant Forms (CRFs) and Unique Recombinant Forms (URFs) in Israel, 2010-2018. Viruses 14(9):1970. |
|
|
Yamaguchi J, Vallari A, McArthur C, Sthreshley L, Cloherty GA, Berg MG, Rodgers MA (2020). Brief Report: Complete Genome Sequence of CG-0018a-01 Establishes HIV-1 Subtype L. Journal of Acquired Immune Deficiency Syndromes 83(3):319-322. |
|
|
Zhang M, Foley B, Schultz AK, Macke JP, Bulla I, Stanke M, Morgenstern B, Korber B, Leitner T (2010). The role of recombination in the emergence of a complex and dynamic HIV epidemic. Retrovirology 7:1-5. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
